Order Article Reprints

Li Q, Demir S, Del Río-Álvarez Á, Maxwell R, Wagner A, Carrillo-Reixach J, Armengol C, Vokuhl C, Häberle B, von Schweinitz D, et al. Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers. 2022; 14(17):4196. https://doi.org/10.3390/cancers14174196

Li, Qian, Salih Demir, Álvaro Del Río-Álvarez, Rebecca Maxwell, Alexandra Wagner, Juan Carrillo-Reixach, Carolina Armengol, Christian Vokuhl, Beate Häberle, Dietrich von Schweinitz, and et al. 2022. "Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma" Cancers 14, no. 17: 4196. https://doi.org/10.3390/cancers14174196

Li, Q., Demir, S., Del Río-Álvarez, Á., Maxwell, R., Wagner, A., Carrillo-Reixach, J., Armengol, C., Vokuhl, C., Häberle, B., von Schweinitz, D., Schmid, I., Cairo, S., & Kappler, R. (2022). Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers, 14(17), 4196. https://doi.org/10.3390/cancers14174196